US 11,654,054 B2
Photodisruptive laser fragmentation of tissue
Ferenc Raksi, Mission Viejo, CA (US)
Assigned to Alcon Inc., Fribourg (CH)
Filed by Alcon Inc., Fribourg (CH)
Filed on May 5, 2021, as Appl. No. 17/308,833.
Application 17/308,833 is a continuation of application No. 15/222,730, filed on Jul. 28, 2016, granted, now 11,026,838.
Application 15/222,730 is a continuation of application No. 14/451,881, filed on Aug. 5, 2014, granted, now 9,427,356, issued on Aug. 30, 2016.
Application 14/451,881 is a continuation of application No. 12/351,784, filed on Jan. 9, 2009, abandoned.
Claims priority of provisional application 61/020,115, filed on Jan. 9, 2008.
Prior Publication US 2021/0322219 A1, Oct. 21, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 9/008 (2006.01); A61F 9/007 (2006.01)
CPC A61F 9/00825 (2013.01) [A61F 9/008 (2013.01); A61F 9/00736 (2013.01); A61B 2217/005 (2013.01); A61F 2009/0087 (2013.01); A61F 2009/00844 (2013.01); A61F 2009/00897 (2013.01)] 17 Claims
OG exemplary drawing
 
1. An ophthalmic laser surgical system, comprising:
a pulsed laser source configured to generate a pulsed laser beam;
optics configured to direct the laser beam towards a target region in a lens of an eye, wherein the lens includes elongated fibers;
a processor configured to:
control the optics to form a laser pattern of a regular array of cells in the target region by creating layers of photodisrupted bubbles to generate cell boundaries and
control the optics to direct pulsed laser source to generate the laser pattern with a spot separation with a higher spot density and/or a higher laser pulse energy to form the cell boundaries that are perpendicular to the elongated fibers, as compared to when the cell boundaries are located parallel to the elongated fibers.